? Shared Resource Management The ACC Shared Resources provide access to specialized technologies, services, training and expertise critical to accelerate research productivity for the 324 ACC members. Each Shared Resource engages with ACC members, trainees, and staff to catalyze basic, translational, clinical and population science cancer research, provide user training and support grant applications for extramural funding and publication of high impact papers. Under the direction of Dr. Celeste Simon, Associate Director for Shared Resources, they are continuously evaluated to ensure that they provide cutting edge technologies and accessible, cost-effective and reliable services that serve the needs of the ACC membership. We propose the following three aims: 1) Support high quality Shared Resources that serve the scientific needs of the ACC membership and catalyze impactful research activity; 2) Ensure stability of and access to ACC and institutional Shared Resources through responsible fiscal management and over-arching usage policies; and 3) Determine the scientific priorities of ACC members and ensure current and future Shared Resources meet membership needs. ACC Administration works closely with ACC Leadership and Dr. Simon in assessing Shared Resources, overseeing management, and ensuring fiscal stability, cost-effectiveness and opportunities for growth. Fiscal oversight of Shared Resources is accomplished through a suite of applications (Path BioResource system), centrally managed by the Perelman School of Medicine (PSOM) and ACC Administration. Strategic planning is regularly undertaken; user feedback and internal advisory boards for each Shared Resources guarantee cutting-edge quality. The percentage of ACC users for each Shared Resource ranges from 32%-100%; the percentage of annual budget support provided through CCSG to support each Shared Resource ranges from 7% to 34%. For the current funding period, we are proposing nine Full Shared Resources ? ACC BioRepository, Biostatistics and Bioinformatics, Comparative Pathology, Flow Cytometry and Cell Sorting, Genomic Analysis, Human Immunology, Metabolomics, Small Animal Imaging, and Transgenic and Chimeric Mouse Facilities. Based on our strategic planning process and in response to members' scientific needs, two of these Shared Resources (ACC BioRepository; Metabolomics) are new, each emerging from Developing Shared Resources of the current funding period. One existing Shared Resource has been expanded in scope (from the Biostatistics Core to the Biostatistics and Bioinformatics Core). Two Developing Shared Resources (Small Animal Radiation and Electronic Phenotyping) are being proposed, based on ACC membership needs. ACC members can utilize over 75 Core Facilities at PSOM; 24 of these undergo formal review by the PSOM Biomedical Research Core Facilities Committee to assure quality. Through ACC support of Shared Resources, members have access to state-of the-art equipment and instrumentation, technical expertise, training and education, all designed to support innovative cutting-edge cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016520-45
Application #
10088754
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-15
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Mazaleuskaya, Liudmila L; Salamatipour, Ashkan; Sarantopoulou, Dimitra et al. (2018) Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS. J Lipid Res 59:564-575
Crisalli, Lisa M; Hinkle, Joanne T; Walling, Christopher C et al. (2018) Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors. Biol Blood Marrow Transplant 24:1203-1208
Rosenfeld, Aaron M; Meng, Wenzhao; Chen, Dora Y et al. (2018) Computational Evaluation of B-Cell Clone Sizes in Bulk Populations. Front Immunol 9:1472
Facompre, Nicole D; Harmeyer, Kayla M; Sahu, Varun et al. (2018) Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer. Oncotarget 9:8985-8998
Fraietta, Joseph A; Lacey, Simon F; Orlando, Elena J et al. (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24:563-571
Shroff, Rachna T; Hendifar, Andrew; McWilliams, Robert R et al. (2018) Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation. JCO Precis Oncol 2018:
Williams, Austin D; Reyes, Sylvia A; Arlow, Renee L et al. (2018) Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged Ann Surg Oncol 25:2875-2883
Anton, Lauren; Sierra, Luz-Jeannette; DeVine, Ann et al. (2018) Common Cervicovaginal Microbial Supernatants Alter Cervical Epithelial Function: Mechanisms by Which Lactobacillus crispatus Contributes to Cervical Health. Front Microbiol 9:2181
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79

Showing the most recent 10 out of 1047 publications